TXMD - TherapeuticsMD - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $312.1. This is a potential upside of $309.49 (11857.85%) from yesterday's end of day stock price of $2.61.

TherapeuticsMD's activity chart (see below) currently has 44 price targets and 81 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 15% with an average time for these price targets to be met of 15.4 days.

Most recent stock forecast was given by LOUISE CHEN from CANTOR FITZGERALD on 17-Aug-2023. First documented stock forecast 21-Sep-2015.

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 11-Jan-2023

$5

$2.77 (124.22%)

$5

2 years 5 months 6 days ago
(17-Aug-2023)

1/2 (50%)

$1.35 (36.99%)

29

Buy

Since 17-Oct-2019

$10

$7.77 (348.43%)

3 years 7 months 16 days ago
(07-Jun-2022)

1/2 (50%)

$0.07 (0.70%)

28

Buy

Since 10-Apr-2017

4 years 5 months 18 days ago
(05-Aug-2021)

0/1 (0%)

$340 (109.68%)

Buy

Since 10-Oct-2016

4 years 8 months 17 days ago
(06-May-2021)

0/2 (0%)

$791 (378.47%)

Buy

Since 04-Apr-2016

4 years 9 months 16 days ago
(07-Apr-2021)

0/9 (0%)

$202 (67.79%)

Show more analysts

Please expand the browser size to see the chart

What is TXMD (TherapeuticsMD) average time for price targets to be met?

On average it took 15.4 days on average for the stock forecasts to be realized with a an average price target met ratio 15

Which analyst has the current highest performing score on TXMD (TherapeuticsMD) with a proven track record?

CHRIS HOWERTON

Which analyst has the most public recommendations on TXMD (TherapeuticsMD)?

Chris Howerton has 0 price targets and 2 ratings on TXMD

Which analyst is the currently most bullish on TXMD (TherapeuticsMD)?

Matthew Andrews with highest potential upside - $747.77

Which analyst is the currently most reserved on TXMD (TherapeuticsMD)?

Annabel Samimy with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?